Brief: Fusion Pharmaceuticals Announces Third Quarter Financial Results

Fusion Pharmaceuticals

08/11/2022 12:54

Nov 8 (Reuters) - Fusion Pharmaceuticals Inc  FUSN.O :
    * FUSION PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2022
FINANCIAL
RESULTS AND CLINICAL PROGRAM UPDATES
    * FPI-1434 PHASE 1 DATA ON TRACK TO BE REPORTED IN FIRST
HALF OF
2023
    * PHASE 1/2 STUDY OF FPI-1966 OPEN AND ENROLLING PATIENTS
WITH
SOLID TUMORS EXPRESSING FGFR3
    * FUSION PHARMACEUTICALS - EXPECTS EXISTING CASH, CASH
EQUIVALENTS,INVESTMENTS AS OF SEPT 30, 2022, TO BE SUFFICIENT TO
FUND OPERATIONS INTO Q3 OF 2024
    * FOR Q3 OF 2022, FUSION REPORTED A NET LOSS OF $24.0
MILLION, OR
$0.55 PER SHARE
    * Q3 EARNINGS PER SHARE VIEW $-0.50 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nCNWblRf5a 
Further company coverage:  FUSN.O 
 ((Reuters.Briefs@thomsonreuters.com;))